EyeControl is a social innovation company, founded to improve the quality of life for locked-in individuals in home and hospital settings. The EyeControl is the first wearable, simple to use, and screenless assistive communication device, enabling communication anytime and anywhere.
AI-powered, eye tracking technology enables locked-in individuals, such as those suffering from ALS/MND, brain injury or stroke, as well as ventilated patients, to communicate solely using eye movements. The EyeControl device can be worn overnight, upon waking, while in the bathroom and during travel. Restoring the ability to communicate socially and/or for emergency purposes is life-altering.
EyeControl has a growing base of customers, is CE marked, FDA listed, ISO certified and is included in the Israeli “Health Basket” and the UK NHS Supply Chain. The device has also been granted reimbursement codes for Medicare/Medicaid in the USA.
Tania Suares, EyeControl’s VP of Operations and Product recently relocated to the UK to support the product and first users in the region. She has met with 19 Augmentative and Assistive Communication hubs throughout the UK and demonstrated the device at innovation and research centres, as well as with actual users. “The most rewarding part of my work here,” says Tania, “is the opportunity to interact directly with individuals that benefit from the EyeControl and witness how the ability to communicate can make a huge difference.”
The EyeControl device for hospital and medical facility use, is currently undergoing clinical trial at Israel’s Sourasky Medical Center ICU and is scheduled for an expanded trial at Emory Hospital in the US. The EyeControl will revolutionize the way locked-in patients communicate inside ICU departments.
“The company founders all have personal experience with locked-in loved ones,” says Or Retzkin, CEO and Co-Founder of EyeControl. “It is deeply moving to help people in the same situation communicate with those dear to them, who benefit from our work”.
The EyeControl is currently being sold in the UK and Israel, and will soon be available in other regions as well. For more information, please contact us: hello@eyecontrol.co.il and/or register to receive our monthly newsletter and stay updated on our progress: https://www.eyecontrol.co.il/contact.
Article meta data
Clicking on any of the links in this section will take you to other articles that have been tagged in the same category.
- Featured in the Karten Summer 2019 Newsletter
- This article is listed in the following subject areas: Technology